International Conference on Pharmaceutical Engineering and Life Sciences
ICPELS
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore innovative methodologies in drug formulation, focusing on enhancing bioavailability and therapeutic efficacy. Participants will discuss recent developments in excipient technology and formulation strategies for complex drug delivery systems.
SDG 3
SDG 4
This session will address the latest strategies in process optimization to improve efficiency and reduce costs in pharmaceutical manufacturing. Topics will include the application of lean manufacturing principles and advanced process control techniques.
SDG 9
This track will delve into the unique challenges associated with the development and production of biopharmaceuticals. Discussions will focus on innovative solutions for scaling up production and ensuring product quality.
SDG 3
SDG 9
This session will highlight the role of molecular biology techniques in the drug development process. Participants will examine case studies demonstrating the impact of genetic engineering and biomolecular analysis on therapeutic advancements.
SDG 3
SDG 4
This track will focus on cutting-edge technologies in drug delivery systems, including nanoparticles, liposomes, and smart drug delivery mechanisms. The session aims to foster discussions on improving targeted delivery and patient compliance.
SDG 3
SDG 9
This session will explore the application of system modeling techniques in biomedical engineering to enhance the understanding of complex biological systems. Participants will discuss computational models that aid in predicting drug behavior and patient outcomes.
SDG 3
SDG 4
This track will cover advanced bioprocessing techniques that optimize the production of biopharmaceuticals and biologics. Emphasis will be placed on fermentation technology, cell culture optimization, and downstream processing.
SDG 3
SDG 9
This session will address the critical aspects of regulatory compliance in pharmaceutical engineering. Discussions will focus on navigating the regulatory landscape to ensure product safety and efficacy throughout the development process.
SDG 9
This track will examine the latest methodologies in quality control and assurance within the life sciences sector. Participants will discuss best practices for maintaining high standards in pharmaceutical production and testing.
SDG 3
SDG 9
This session will explore the intersection of therapeutic development and healthcare innovation, focusing on novel therapeutic approaches and technologies. Participants will share insights on how innovation can drive improvements in patient care.
SDG 3
SDG 9
This track will highlight the role of bioengineering in addressing contemporary healthcare challenges. Discussions will include the development of bioengineered products and systems that enhance patient outcomes and healthcare delivery.
SDG 3
SDG 9